262 related articles for article (PubMed ID: 25923215)
1. Delivery of GM-CSF to Protect against Influenza Pneumonia.
Subramaniam R; Hillberry Z; Chen H; Feng Y; Fletcher K; Neuenschwander P; Shams H
PLoS One; 2015; 10(4):e0124593. PubMed ID: 25923215
[TBL] [Abstract][Full Text] [Related]
2. GM-CSF in the lung protects against lethal influenza infection.
Huang FF; Barnes PF; Feng Y; Donis R; Chroneos ZC; Idell S; Allen T; Perez DR; Whitsett JA; Dunussi-Joannopoulos K; Shams H
Am J Respir Crit Care Med; 2011 Jul; 184(2):259-68. PubMed ID: 21474645
[TBL] [Abstract][Full Text] [Related]
3. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.
Ballinger MN; Paine R; Serezani CH; Aronoff DM; Choi ES; Standiford TJ; Toews GB; Moore BB
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):766-74. PubMed ID: 16474098
[TBL] [Abstract][Full Text] [Related]
4. Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production.
Subramaniam R; Barnes PF; Fletcher K; Boggaram V; Hillberry Z; Neuenschwander P; Shams H
J Infect Dis; 2014 Jun; 209(11):1827-36. PubMed ID: 24367039
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury.
Paine R; Wilcoxen SE; Morris SB; Sartori C; Baleeiro CE; Matthay MA; Christensen PJ
Am J Pathol; 2003 Dec; 163(6):2397-406. PubMed ID: 14633611
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.
Paine R; Preston AM; Wilcoxen S; Jin H; Siu BB; Morris SB; Reed JA; Ross G; Whitsett JA; Beck JM
J Immunol; 2000 Mar; 164(5):2602-9. PubMed ID: 10679099
[TBL] [Abstract][Full Text] [Related]
7. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung.
Willinger T; Rongvaux A; Takizawa H; Yancopoulos GD; Valenzuela DM; Murphy AJ; Auerbach W; Eynon EE; Stevens S; Manz MG; Flavell RA
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2390-5. PubMed ID: 21262803
[TBL] [Abstract][Full Text] [Related]
8. Lower respiratory tract delivery, airway clearance, and preclinical efficacy of inhaled GM-CSF in a postinfluenza pneumococcal pneumonia model.
Umstead TM; Hewage EK; Mathewson M; Beaudoin S; Chroneos ZC; Wang M; Halstead ES
Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L571-L579. PubMed ID: 31994895
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization.
Halstead ES; Umstead TM; Davies ML; Kawasawa YI; Silveyra P; Howyrlak J; Yang L; Guo W; Hu S; Hewage EK; Chroneos ZC
Respir Res; 2018 Jan; 19(1):3. PubMed ID: 29304863
[TBL] [Abstract][Full Text] [Related]
10. Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages.
Subramaniam R; Mukherjee S; Chen H; Keshava S; Neuenschwander P; Shams H
Mucosal Immunol; 2016 Jul; 9(4):873-83. PubMed ID: 26577570
[TBL] [Abstract][Full Text] [Related]
11. GM-CSF modulates pulmonary resistance to influenza A infection.
Sever-Chroneos Z; Murthy A; Davis J; Florence JM; Kurdowska A; Krupa A; Tichelaar JW; White MR; Hartshorn KL; Kobzik L; Whitsett JA; Chroneos ZC
Antiviral Res; 2011 Nov; 92(2):319-28. PubMed ID: 21925209
[TBL] [Abstract][Full Text] [Related]
12. The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model.
Schloer S; Hübel N; Masemann D; Pajonczyk D; Brunotte L; Ehrhardt C; Brandenburg LO; Ludwig S; Gerke V; Rescher U
FASEB J; 2019 Nov; 33(11):12188-12199. PubMed ID: 31398292
[TBL] [Abstract][Full Text] [Related]
13. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair.
Cakarova L; Marsh LM; Wilhelm J; Mayer K; Grimminger F; Seeger W; Lohmeyer J; Herold S
Am J Respir Crit Care Med; 2009 Sep; 180(6):521-32. PubMed ID: 19590023
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation.
Naessens T; Schepens B; Smet M; Pollard C; Van Hoecke L; De Beuckelaer A; Willart M; Lambrecht B; De Koker S; Saelens X; Grooten J
J Allergy Clin Immunol; 2016 Mar; 137(3):700-9.e9. PubMed ID: 26560044
[TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
[TBL] [Abstract][Full Text] [Related]
16. Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage.
Joshi PC; Applewhite L; Ritzenthaler JD; Roman J; Fernandez AL; Eaton DC; Brown LA; Guidot DM
J Immunol; 2005 Nov; 175(10):6837-45. PubMed ID: 16272341
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice.
Huang H; Li H; Zhou P; Ju D
Cytokine; 2010 Aug; 51(2):151-7. PubMed ID: 20427198
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor.
Bilyk N; Holt PG
J Exp Med; 1993 Jun; 177(6):1773-7. PubMed ID: 8496690
[TBL] [Abstract][Full Text] [Related]
19. Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia.
Todd EM; Ramani R; Szasz TP; Morley SC
Sci Adv; 2019 Aug; 5(8):eaax3387. PubMed ID: 31453341
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung.
Berclaz PY; Shibata Y; Whitsett JA; Trapnell BC
Blood; 2002 Dec; 100(12):4193-200. PubMed ID: 12393686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
